bn 52063 has been researched along with Shock, Septic in 2 studies
*Shock, Septic: Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guinot, P | 1 |
Braquet, P; Etienne, A; Guilmard, C; Hecquet, F; Soulard, C | 1 |
1 review(s) available for bn 52063 and Shock, Septic
Article | Year |
---|---|
Clinical experience with platelet-activating factor antagonists. Past, present, and near future.
Topics: Animals; Azepines; Clinical Trials as Topic; Graft Rejection; Humans; Kidney Transplantation; Lactones; Plant Extracts; Platelet Activating Factor; Randomized Controlled Trials as Topic; Shock, Septic; Thienopyridines; Triazoles | 1994 |
1 other study(ies) available for bn 52063 and Shock, Septic
Article | Year |
---|---|
Inhibition of rat endotoxin-induced lethality by BN 52021 and BN 52063, compounds with PAF-acether antagonistic effect and protease-inhibitory activity.
Topics: Animals; Diterpenes; Endotoxins; Ginkgolides; Lactones; Male; Phospholipases A; Plant Extracts; Platelet Activating Factor; Protease Inhibitors; Rats; Rats, Inbred Strains; Shock, Septic; Trypsin | 1987 |